Immunoassay controls and the use thereof
The present invention relates to compositions and methods use in designing immunoassay controls. In various aspects, the invention provides synthetic peptides comprising the sequence CPRRPYIL or an analog thereof; ELAGLGFAELQC or an analog thereof; and CDWRKNIDAL or an analog thereof; specific binding reagents that bind to a CPRRPYIL, ELAGLGFAELQC or CDWRKNIDAL peptide; methods of producing such reagents; and assays utilizing such reagents to provide assay controls signals that are unrelated to the measurement of the analyte or analytes of interest in that no reagents used in the analyte assay(s) contribute to the control signal.
1. A device, comprising:
a substrate defining at least one diagnostic lane;
a sample application zone;
a dried reagent zone; and
a detection zone comprising at least one control zone and at least one assay zone;
wherein at least one of the dried reagent zone or the control zone comprises a peptide having 87.5% identify to SEQ ID No: 1.
2. The device of claim 1 , wherein the control zone comprises the peptide.
3. The device of claim 2 , wherein the peptide is immobilized in the control zone.
4. The device of claim 3 , wherein the dried reagent zone comprises an agent conjugated to a detectable label.
5. The device of claim 1 , wherein the dried reagent zone comprises the peptide.
6. The device of claim 5 , wherein the peptide is conjugated to a detectable label.
7. A device, comprising:
a substrate defining at least one diagnostic lane;
a sample application zone;
a dried reagent zone; and
a detection zone comprising at least one control zone and at least one assay zone;
wherein the at least one control zone comprises a peptide of SEQ ID NO: 1.
8. The device of claim 7 , wherein the peptide is immobilized in the control zone.
9. The device of claim 8 , wherein the dried reagent zone comprises an agent conjugated to a detectable label.